Trial Profile
Patient Centered Outcomes in Rosacea: An Exploratory Multi-media Analysis of the Patient Experience on Oracea
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Aug 2022
Price :
$35
*
At a glance
- Drugs Doxycycline hyclate (Primary)
- Indications Bacterial infections; Rosacea
- Focus Therapeutic Use
- Sponsors Galderma Research & Development
- 12 Jun 2013 New trial record
- 01 Jun 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.